Why Walgreens Boots Alliance Rose Even on a Bad Day for the Markets
Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by 3:30 p.m. ET. That gain was still notable, since the broader markets were down significantly on the day.News reports circulated with further details on a potential buyout of the company by private equity firm Sycamore Partners, which has been in talks to buy the troubled pharmacy since late 2024.According to people familiar with the matter and reported in the Financial Times, Sycamore Partners is proposing to split Walgreens into three separate companies: the main Walgreens pharmacy in the U.S., the Boots pharmacy and chemist in the U.K., and specialty pharmaceutical unit Shields Health Solutions. Moreover, the sources said Sycamore appeared to have the necessary financing lined up.Continue reading

Shares of Walgreens Boots Alliance (NASDAQ: WBA) rose on Thursday, up as much as 7.3% before settling into a 2.2% gain by 3:30 p.m. ET. That gain was still notable, since the broader markets were down significantly on the day.
News reports circulated with further details on a potential buyout of the company by private equity firm Sycamore Partners, which has been in talks to buy the troubled pharmacy since late 2024.
According to people familiar with the matter and reported in the Financial Times, Sycamore Partners is proposing to split Walgreens into three separate companies: the main Walgreens pharmacy in the U.S., the Boots pharmacy and chemist in the U.K., and specialty pharmaceutical unit Shields Health Solutions. Moreover, the sources said Sycamore appeared to have the necessary financing lined up.